Tranche Update on Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 16, 2022.
October 20, 2022 at 05:44 am IST
Share
From September 16, 2022 to October 13, 2022, the company has repurchased 100,000 shares, representing 0.37% for KRW 749.64 million. With this, the company has completed the repurchase of 100,000 shares, representing 0.37% for KRW 749.64 million under the buyback announced on September 16, 2022.
KYUNG DONG PHARMACEUTICAL CO.,LTD. is a Korea-based company engaged in the manufacture and marketing of pharmaceutical products. The Companyâs products include liver therapies, gastrointestinal drugs, antimigraine drugs, antiviral, anti-obesity medications, antibacterial drugs, antidiabetic drugs, antifungal, allergy medications, antispasmodics, antihistamines, vitamins, as well as drugs for osteoporosis, cardiovascular, muscle relaxant, neuropathic and other diseases. It also provides various over-the-counter (OTC) drugs, such as anti-inflammatory medicines, antiviral drugs, antihistamine drugs, gastrointestinal drugs and others. In addition, the Company engages in the leasing of real estate, and distribution of snowboards and health functional food.
KYUNG DONG PHARMACEUTICAL CO., LTD. 